0,1,2,3,4,5,6
6,,,,,Antiviral Chemistry and Chemotherapy,
Table 3. Evaluation of prodrug compounds 18â€“20 against VZV and CMV in HEL cells.,,,,,,
,Antiviral activity EC50 (lM)a,,,,Cytotoxicity (lM),
,Ã¾,,,,,
,"TK
VZV",TKâ€“ VZV,HCMV,,,
,,,,,Cell morphology,Cell growth
Compound,OKA strain,07-1 strain,AD-169 strain,Davis strain,(MCC)b,(CC50)c
17,>100,>100,>100,>100,>100,NDd
18,0.10 (cid:3) 0.05,0.64 (cid:3) 0.77,0.20 (cid:3) 0.28,0.05 (cid:3) 0.05,100,10 (cid:3) 0
19,>20,>100,63,55,(cid:4)100,ND
20,22,26.5,63 (cid:3) 19,6.2 (cid:3) 6.8,>100,100 (cid:3) 0
Acyclovir,2.23 (cid:3) 2.16,98 (cid:3) 61,ND,ND,>440,>440
Brivudin,0.019 (cid:3) 0.010,19.6 (cid:3) 23.0,ND,ND,(cid:4)300,168 (cid:3) 41
Ganciclovir,ND,ND,10.0 (cid:3) 10.2,5.5 (cid:3) 4.4,>350,(cid:4)317 (cid:3) 98
Cidofovir,0.92 (cid:3) 0.38,0.78 (cid:3) 0.32,ND,ND,>300,170 (cid:3) 61
